Francis Chi
Chief Executive Officer at WALCOM GROUP LIMITED
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kin Chung Cheng | M | 61 |
Antiviral Technologies, Inc.
 Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong.
Obio Pharmaceutical Holdings Ltd.
 Obio Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Obio Pharmaceutical Holdings Ltd. is a holding There is no available country named vg company with interests in the pharmaceutical business. The private company was founded by Francis Chi. | 16 years |
| Bill Piu Chan | M | 62 |
Antiviral Technologies, Inc.
Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | 15 years |
| Jess Gilbert Thoene | M | 81 |
Antiviral Technologies, Inc.
Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | 14 years |
| Yee Ying Leung | F | 62 |
Antiviral Technologies, Inc.
Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | 10 years |
| Buddhinunta-Opas Paitoon | M | - | 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Siu Fai Wong | M | 65 | 13 years | |
| Yuet Leung Wong | M | 75 | 17 years | |
| Hong Xun Yang | M | 68 | 10 years | |
| Chian Tan Yong | M | 62 | 19 years | |
| Timothy Robert Nelson | M | 51 | 13 years | |
| Susan Preston | F | - |
Seattle University
| 3 years |
| Jon Roudebush | M | - |
Seattle University
| 4 years |
| Kazuo Fujisawa | M | - |
Seattle University
| 4 years |
| Julie Ann Lawrence | F | - |
Seattle University
| 5 years |
| Abdulrahman Al-Rashed | M | - |
Seattle University
| 4 years |
| Chi Chiu Wong | M | 68 | 12 years | |
| Robert Shaw | M | - |
Seattle University
| 5 years |
| Dino Rossi | M | 64 |
Seattle University
| 4 years |
| Eddie Chan | M | 63 | 9 years | |
| Abdul Mohsin Al-Rashed | M | 68 |
Seattle University
| 4 years |
| Hwai Ming Chan | F | - | - | |
| Man Chan Kin | M | 64 | - | |
| Michael Lester Amato | M | 67 |
Seattle University
| 4 years |
| Paul N. Bialek | M | - |
Seattle University
| 4 years |
| Mohammad Issa Hamad Al-Hassan Al-Mohannadi | M | - |
Seattle University
| 2 years |
| Alfons Irawan | M | - |
Seattle University
| 4 years |
| Royston Frederick Drucker | M | 69 | 4 years | |
| John Laffey | M | - |
Seattle University
| 2 years |
| Glenn R. McQuiston | M | 69 |
Seattle University
| 4 years |
| Anthony E. Hubbard | M | - |
Seattle University
| 4 years |
| Martha J. Dawson | F | - |
Seattle University
| 4 years |
| Steven R. Horton | M | - |
Seattle University
| 4 years |
| David A. Bley | M | - |
Seattle University
| 1 years |
| Stephen G. Delmore | M | - |
Seattle University
| 4 years |
| Joe K. Piper | M | - |
Seattle University
| 3 years |
| Guðmundur Jóhann Jónsson | M | - |
Seattle University
| 4 years |
| Dana Kent Harken | M | - |
Seattle University
| 4 years |
| Brian Charneski | M | 62 |
Seattle University
| 4 years |
| Robb Kenyon | M | 58 |
Seattle University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 24 | 61.54% |
| China | 11 | 28.21% |
| Hong Kong | 4 | 10.26% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Francis Chi
- Personal Network